Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial

Biswal, S.; Borja-Tabora, C.; Vargas, L.M.; Fernando, A.D.; Gunasekera, D.

Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial

Files

Efficacy of a tetravalent dengue vaccine in healthy children.pdf (496.52 KB)

Date

2020

Authors

Citation

Biswal, S., et al. (2020). Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial. www.thelancet.com Vol 395 May 2, 2020.

URI

http://dr.lib.sjp.ac.lk/handle/123456789/12304

Collections

2020 - Medical

Full item page

Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial

Files

Date

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

Citation

URI

Collections

Endorsement

Review

Supplemented By

Referenced By